Reasoning
The stock can work from revenue scale rather than multiple expansion. My case assumes Innodata keeps its current AI demand, broadens beyond the largest customer, and adds higher-capture assurance, healthcare verification, and sovereign or regulated delivery. That mix supports strong growth with some operating leverage, while the valuation still settles below today's level because the business should remain partly services-led.